Ryuichi Noguchi
Kashihara-shi, 6348522, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 48 publications
Creatinine/Cystatin C Ratio as a Surrogate Marker for Sarcopenia in Hepatitis-C-Associated Liver Cirrhosis After Achieving a Sustained Virologic Response.
Journal: Current issues in molecular biology
Published: January 06, 2026
Clinical Significance of Marginal Zinc Deficiency as a Predictor of Covert Hepatic Encephalopathy in Patients with Liver Cirrhosis.
Journal: International journal of molecular sciences
Published: April 04, 2025
Low Intrahepatic Distant Recurrence Rate Following RFA Using Linear Mode in Patients With Hepatocellular Carcinoma.
Journal: JGH open : an open access journal of gastroenterology and hepatology
Published: December 31, 2024
Fibrosis stage is an independent predictor of liver-related complications in primary biliary cholangitis.
Journal: Hepatology research : the official journal of the Japan Society of Hepatology
Published: October 24, 2024
Risk Factors for Intrahepatic Distant Recurrence After Radiofrequency Ablation for Hepatocellular Carcinoma.
Journal: Digestive diseases and sciences
Published: September 13, 2024
Macrophage Activation Markers Predict Liver-Related Complications in Primary Biliary Cholangitis.
Journal: International journal of molecular sciences
Published: August 11, 2022
Comparison of Ablation Area and Change in Functional Liver Reserve after Radiofrequency Ablation for Hepatocellular Carcinoma Using the arfa® and VIVA® Systems.
Journal: Journal of clinical medicine
Published: December 19, 2021
Association between Equol Production Status and Nonalcoholic Steatohepatitis.
Journal: International journal of molecular sciences
Published: September 21, 2021
Protein-losing gastroenteropathy complicated with asymptomatic primary biliary cholangitis, refractory to immunosuppressant, and improved by Helicobacter pylori eradication: a case report.
Journal: BMC gastroenterology
Published: June 10, 2021
Effect of combined farnesoid X receptor agonist and angiotensin II type 1 receptor blocker on ongoing hepatic fibrosis.
Journal: Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology
Published: April 08, 2021
Last Updated: 09/26/2026